NYSE
DNA
Ginkgo Bioworks Holdings, Inc.
- Health Care
- Listed 2021
- 1 day
- −9.3%
- 1 month
- −9.0%
- 1 year
- −39.1%
$8.50 · Mkt cap $528M
At the 6 Aug 2026 close
NYSE
Ginkgo Bioworks Holdings, Inc.
$8.50 · Mkt cap $528M
At the 6 Aug 2026 close
Ginkgo Bioworks Holdings, Inc. trades under the ticker DNA on NYSE, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2021. Its market capitalisation is $528M. The last closing price was $8.50, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −39.1%, and −9.0% over the past month. Returns are price returns and exclude dividends.
This page exists because DNA is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.